Advanz Agrees Multi-Market Omalizumab Deal With Alvotech

Gains Rights To Market Xolair Biosimilar In Europe, Canada And Australiasia

 
• By David Wallace
  
Blue lungs with world map
Advanz has gained international rights to the asthma treatment • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business